Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
5414-8 CD10 ACnc WBC Pt Qn     DEPRECATED Deprecated CD10 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5414-8                 0 Deprecated CD10 WBC-aCnc           Arbitrary concentration; CALLA; CELL MARKERS; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Enkephalinase; gp100; J5; Leukocytes; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54140-9 History of diseases Hx ^Patient Pt Nom USSG-FHT   ACTIVE History of diseases [USSG-FHT]   MAJ DefinitionDescription                   SURVEY.USSGFHT   54140-9   USSG-FHT             0         N   Diseases Hx; FHH; H/O; History; Hx; Nominal; Point in time; Random; Survey; SURVEY.USSGFHT; US Surgeon General; US Surgeon General family health portrait 2.56 2.26                     Changed Property from "Find" to "Hx" per 8/2015 Clinical LOINC Committee decision 0
54141-7 Current age Time ^Family member Pt Qn USSG-FHT   ACTIVE Current age Family member [USSG-FHT]   MIN DefinitionDescription     years             SURVEY.USSGFHT   54141-7   USSG-FHT             0         N   Fam Mem; FHH; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.USSGFHT; US Surgeon General; US Surgeon General family health portrait 2.44 2.26               a       0
54142-5 Candida sp DNA PrThr Vag Pt Ord Probe.amp.sig   ACTIVE Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification   MIN DefinitionDescription                   MICRO   54142-5   Probe.amp.sig     Both       0 Candida DNA Vag Ql Probe+sig amp       N   Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Monilia; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; species; spp; Thrush; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54143-3 Gardnerella vaginalis DNA PrThr Vag Pt Ord Probe.amp.sig   ACTIVE Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification   MIN DefinitionDescription                   MICRO   54143-3   Probe.amp.sig     Both       0 G vaginalis DNA Vag Ql Probe+sig amp       N   Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54144-1 Trichomonas vaginalis DNA PrThr Vag Pt Ord Probe.amp.sig   ACTIVE Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification   MIN DefinitionDescription                   MICRO   54144-1   Probe.amp.sig     Both       0 T vaginalis DNA Vag Ql Probe+sig amp       N   Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; T vaginalis; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.73 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54145-8 Bacterial vaginosis & vaginitis DNA panel - Vag Pt - Probe.amp.sig   ACTIVE Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification   MIN DefinitionDescription                   PANEL.MICRO   54145-8   Probe.amp.sig     Order       0 Vaginosis/itis DNA Pnl Vag Probe+sig amp       N   Amplif; Amplification; Amplified; Bact; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; HC; HPA; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Random; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid; Vaginal pathogens; Vaginosis/itis DNA Pnl 2.73 2.27   Panel                   0
54146-6 Mycobacterium tuberculosis Ab.IgG ACnc Ser Pt Qn IA   ACTIVE Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay   MIN DefinitionDescription                   MICRO   54146-6   IA     Both       0 M tb IgG Ser IA-aCnc       N   ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M tb; M tuberculosis; MEIA; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; TB; Tuberculosis 2.69 2.27               [arb'U]/mL     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
54147-4 Autoantibodies Imp Ser Pt Nar IF rat liver+stomach+kidney substrate   ACTIVE Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) rat liver+stomach+kidney substrate Narrative   MIN DefinitionDescription                   SERO   54147-4   IF rat liver+stomach+kidney substrate     Observation       0 Auto Ab Ser Rat liv+stom+kid-Imp       N   ACIF; Anticomplement Immunofluorescence; Auto Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Rat liv+stom+kid; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.7 2.27                       0
54148-2 Autoantibodies Imp Ser Pt Nar IF Hep2 substrate   ACTIVE Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) Hep2 substrate Narrative   MIN DefinitionDescription                   SERO   54148-2   IF Hep2 substrate     Observation       0 Auto Ab Ser HEp2 subst-Imp       N   ACIF; Anticomplement Immunofluorescence; Auto Ab; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.27 2.27                       0
54149-0 Nuclear Ab pattern.homogeneous PrThr Ser Pt Ord IF   ACTIVE Homogenous nuclear Ab pattern [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       ANA homogenous pos.           SERO   54149-0   IF     Observation       0 ANA Homogen Ser Ql IF       N   ACIF; ANA; ANA Homogen; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; FA; FANA; Fluorescent antibody; Fluoresent; Homogen; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.58 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
5415-5 CD10+CD20+ ACnc WBC Pt Qn     DEPRECATED Deprecated CD10+CD20+   MIN DefinitionDescription                   CELLMARK   5415-5                 0 Deprecated CD10+CD20+ WBC-aCnc           Arbitrary concentration; B1; B-1; Bp35; CALLA; CELL MARKERS; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Enkephalinase; gp100; J5; Leu16; Leu-16; Leukocytes; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54150-8 Centriole Ab PrThr Ser Pt Ord IF   DEPRECATED Deprecated Centriole Ab [Presence] in Serum by Immunofluorescence   DEL DefinitionDescription       MSA centriole antibody pos.           SERO   54150-8   IF     Both       0 Deprecated Centriole Ab Ser Ql IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CE; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA CE; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.7 2.27       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54151-6 Centriole Ab Titr Ser Pt Qn IF   DEPRECATED Deprecated Centriole Ab [Titer] in Serum by Immunofluorescence   DEL DefinitionDescription     titer MSA centriole antibodies 1:640.           SERO   54151-6   IF     Both       0 Deprecated Centriole Ab Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CE; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA CE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.7 2.27       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54152-4 Nuclear mitotic apparatus Ab PrThr Ser Pt Ord IF   ACTIVE Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       MSA NuMA antibodies pos.           SERO   54152-4   IF     Both       0 NuMA Ab Ser Ql IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA NuMA; MSA-1; Nuc; NuMA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.73 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54153-2 Nuclear mitotic apparatus Ab Titr Ser Pt SemiQn IF   ACTIVE Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     Titer MSA NuMA antibody 1:1280.           SERO   54153-2   IF     Both       0 NuMA Ab Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MSA NuMA; MSA-1; Nuc; NuMA; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.27               {titer}       0
54154-0 Nuclear Ab pattern.intercellular bridge PrThr Ser Pt Ord IF   ACTIVE Intercellular bridge nuclear Ab pattern [Presence] in Serum by Immunofluorescence   NAM DefinitionDescription       MSA midbody antibodies pos.           SERO   54154-0   IF     Both       0 ANA intercell bridge Ser Ql IF       N   ACIF; ANA; ANA intercell bridge; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Midbody; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stem body; Time Resolved Fluorescence; TRF 2.7 2.27                     Release 2.70: COMPONENT: Updated Component from "Midbody Ab" to align with current nomenclature (https://www.anapatterns.org/view_pattern.php?pattern=27); Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54155-7 Nuclear Ab pattern.intercellular bridge Titr Ser Pt SemiQn IF   ACTIVE Intercellular bridge nuclear Ab pattern [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     Titer MSA midbody antibodies 1:160.           SERO   54155-7   IF     Both       0 ANA intercell bridge Titr Ser IF       N   ACIF; ANA; ANA intercell bridge; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Midbody; NA; Nuc; Point in time; Random; Serology; Serum; SmQn; SR; Stem body; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.27               {titer}     Release 2.70: COMPONENT: Updated Component from "Midbody Ab" to align with current nomenclature (https://www.anapatterns.org/view_pattern.php?pattern=27); 0
54156-5 RNA polymerase I Ab PrThr Ser Pt Ord IF   ACTIVE RNA polymerase I Ab [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       RNA polymerase pos.           SERO   54156-5   IF     Both       0 RNAp I Ab Ser Ql IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Point in time; Pol I; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp I; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.56 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54157-3 RNA polymerase I Ab Titr Ser Pt SemiQn IF   ACTIVE RNA polymerase I Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     Titer RNA polymerase antibodies 1:160.           SERO   54157-3   IF     Both       0 RNAp I Ab Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Pol I; Random; Ribonucleic acid; RNAp I; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.27               {titer}       0
54158-1 Pancytokeratin Ab PrThr Ser Pt Ord IF   ACTIVE Pancytokeratin Ab [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       Pancytokeratin antibody pos.           SERO   54158-1   IF     Both       0 Pan CK Ab Ser Ql IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pan CK; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.56 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54159-9 Pancytokeratin Ab Titr Ser Pt SemiQn IF   ACTIVE Pancytokeratin Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer Pancytokeratin antibody 1:160.           SERO   54159-9   IF     Both       0 Pan CK Ab Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Pan CK; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.27               {titer}       0
5416-3 CD100 ACnc WBC Pt Qn     DEPRECATED Deprecated CD100 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5416-3                 0 Deprecated CD100 WBC-aCnc           Arbitrary concentration; CELL MARKERS; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; SEMA4D; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54160-7 Ki Ab PrThr Ser Pt Ord     ACTIVE Ki Ab [Presence] in Serum   MIN DefinitionDescription       Ki-AB: pos.           SERO   54160-7         Both       0 Ki Ab Ser Ql       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ki/SL; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SL; SL-Ki; SR 2.56 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
54161-5 Cytoplasmic Ab pattern.PL-7+PL-12 PrThr Ser Pt Ord IF   ACTIVE Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence   MIN DefinitionDescription       Staining pattern indicative of PL-7/PL-12: pos.           SERO   54161-5   IF     Both       0 CA Pat PL-7+PL-12 Ser Ql IF       N   ACIF; Anticomplement Immunofluorescence; CA Pat; CA Pat PL-7+PL-12; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; PL12; PL7; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF 2.56 2.27                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found